Neuromodulation of cortical circuits in health and disease

健康和疾病中皮质回路的神经调节

基本信息

  • 批准号:
    8722034
  • 负责人:
  • 金额:
    $ 40.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-16 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cortical microcircuits, comprising specialized neuron subpopulations and their selective synaptic connections, form functionally segregated output channels to other cortical and subcortical targets. The activity of cortical microcircuits is regulated by a number of "modulatory" neurotransmitters, such as serotonin (5-HT), that optimize circuit performance for specific cognitive tasks, and which are implicated in a wide spectrum of mental health disorders. For instance, disrupted 5-HT signaling contributes to schizophrenia, depression, and anxiety, while serotonergic drugs are widely used to treat these disorders. However, despite their functional and clinical importance, little is known about how modulatory transmitters selectively regulate the activity of cortical neuron subpopulations subserving specific functional roles within cortical microcircuits. Our long-term goal is to characterize the functional impact of modulatory neurotransmitters on cortical microcircuit function. The research proposed here represents an important first step toward this goal by identifying key cellular and synaptic components of cortical microcircuits differentially regulated by 5-HT. Serotonergic signaling in excitatory cortical neurons relies primarily on two G-protein coupled receptors, 5-HT1A (1A) and 5-HT2A (2A), that have opposing influences on neuron excitability. Based on recent results showing commissural/callosal (COM) projection neurons are selectively excited by 5-HT, our central hypothesis is that endogenous 5-HT acts to selectively enhance the activity of neurons participating in specific executive functions, while suppressing the bulk of cortical output to subcortical structures. Our first aim is to identify the cellular components of cortical circuits that are functionally excited or inhibited by endogenous 5-HT. This will be accomplished in a mouse model in which channelrhodopsin-2 is selectively expressed in 5-HT neurons, and using fluorescent retrograde tracers delivered in vivo. Our second aim is to characterize synaptic connectivity among populations of 5-HT-excited neurons to determine whether they form networks capable of the sustained activity associated with executive functions. Finally, our third aim will confirm in behaving animals preferential activatio of COM or other 5-HT-excited neuron populations by 2A agonists, fear conditioning, and extinction of conditioned fear. These aims are innovative in combining anatomical, physiological, optogenetic, and behavioral approaches to characterize selective modulation of cellular components and synaptic connections underlying functionally defined cortical output channels. The results will be significant in providing a framework for understanding the functional role of 5 HT in regulating the output of cortical circuits. The new knowledge gained will provide insight into how 5-HT facilitates normal cognition and behavior, and why dysregulation of serotonergic signaling in the cerebral cortex leads to the behavioral deficits observed in schizophrenia, depression, and other mental health disorders.
描述(由申请人提供):包括专门的神经元亚群及其选择性突触连接的皮质微电路形成到其他皮质和皮质下目标的功能隔离的输出通道。皮质微回路的活动受许多“调节性”神经递质(如5-羟色胺(5-HT))的调节,这些神经递质优化了特定认知任务的回路性能,并且与广泛的精神健康障碍有关。例如,中断的5-HT信号有助于精神分裂症,抑郁症和焦虑症,而多巴胺能药物被广泛用于治疗这些疾病。然而,尽管它们的功能和临床的重要性,很少有人知道如何调节递质选择性地调节皮质神经元亚群subserving特定的功能角色内皮层微电路的活动。 我们的长期目标是表征调节性神经递质对皮质微电路功能的功能影响。通过识别差异调节的皮层微回路的关键细胞和突触成分,这里提出的研究代表了朝着这一目标迈出的重要的第一步 5-HT。兴奋性皮质神经元中的5-羟色胺能信号主要依赖于两种G蛋白偶联受体5-HT 1A(1A)和5-HT 2A(2A),它们对神经元兴奋性具有相反的影响。基于最近的结果显示连合/胼胝体(COM)投射神经元选择性兴奋5-HT,我们的中心假设是,内源性5-HT的行为,选择性地增强参与特定的执行功能的神经元的活动,同时抑制大部分的皮质输出到皮质下结构。我们的首要目标是确定 皮质回路的细胞成分,在功能上被内源性5-HT兴奋或抑制。这将在其中通道视紫红质-2在5-HT神经元中选择性表达的小鼠模型中并且使用体内递送的荧光逆行示踪剂来实现。我们的第二个目标是表征5-HT兴奋的神经元群体之间的突触连接,以确定它们是否形成能够与执行功能相关的持续活动的网络。最后,我们的第三个目标将在行为动物中证实2A激动剂对COM或其他5-HT兴奋的神经元群体的优先激活、恐惧条件化和条件恐惧的消退。这些目标是创新的结合解剖学,生理学,光遗传学和行为的方法来表征选择性调制的细胞成分和突触连接功能定义的皮层输出通道。结果对于提供理解5的功能作用的框架具有重要意义 HT在调节皮层回路输出中的作用。所获得的新知识将深入了解5-HT如何促进正常的认知和行为,以及为什么大脑皮层中多巴胺能信号的失调会导致精神分裂症,抑郁症和其他精神健康疾病中观察到的行为缺陷。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Allan T Gulledge其他文献

Allan T Gulledge的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Allan T Gulledge', 18)}}的其他基金

Coordinated modulation of cortical circuits by serotonin and acetylcholine
血清素和乙酰胆碱对皮质回路的协调调节
  • 批准号:
    10665047
  • 财政年份:
    2021
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
  • 批准号:
    10612415
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
  • 批准号:
    10401949
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
  • 批准号:
    9815038
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cortical circuitry and mechanisms underlying remote cue-specific fear memory and extinction
远程线索特异性恐惧记忆和消退背后的皮层电路和机制
  • 批准号:
    10417350
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
Neuromodulation of cortical circuits in health and disease
健康和疾病中皮质回路的神经调节
  • 批准号:
    8576665
  • 财政年份:
    2013
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cholinergic signaling in cortical neurons: a unifying hypothesis
皮质神经元中的胆碱能信号传导:一个统一的假设
  • 批准号:
    7888378
  • 财政年份:
    2008
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cholinergic signaling in cortical neurons: a unifying hypothesis
皮质神经元中的胆碱能信号传导:一个统一的假设
  • 批准号:
    7655524
  • 财政年份:
    2008
  • 资助金额:
    $ 40.5万
  • 项目类别:
Cholinergic signaling in cortical neurons: a unifying hypothesis
皮质神经元中的胆碱能信号传导:一个统一的假设
  • 批准号:
    8089261
  • 财政年份:
    2008
  • 资助金额:
    $ 40.5万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 40.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 40.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了